Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,896 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors.
Nakamura Y, Hasegawa H, Tsuji M, Udaka Y, Mihara M, Shimizu T, Inoue M, Goto Y, Gotoh H, Inagaki M, Oguchi K. Nakamura Y, et al. Among authors: hasegawa h. World J Diabetes. 2015 Jun 25;6(6):840-9. doi: 10.4239/wjd.v6.i6.840. World J Diabetes. 2015. PMID: 26131325 Free PMC article. Review.
Anti-inflammatory effects of linagliptin in hemodialysis patients with diabetes.
Nakamura Y, Tsuji M, Hasegawa H, Kimura K, Fujita K, Inoue M, Shimizu T, Gotoh H, Goto Y, Inagaki M, Oguchi K. Nakamura Y, et al. Among authors: hasegawa h. Hemodial Int. 2014 Apr;18(2):433-42. doi: 10.1111/hdi.12127. Epub 2014 Jan 10. Hemodial Int. 2014. PMID: 24405885 Clinical Trial.
Risks and Prevention of Severe Respiratory Syncytial Virus Infection among Infants and Children with Pulmonary Hypoplasia, Airway Stenosis, Congenital Esophageal Atresia, Inborn Errors of Metabolism, or Neuromuscular Diseases in Japan.
Mori M, Ito Y, Ishiwada N, Ito K, Shinjoh M, Tsugawa T, Funaki T, Furuichi M, Hoshino T, Miyairi I, Kondo T, Hinoki A, Wada M, Okada K, Korematsu S, Tanuma N, Hasegawa H, Hosoi K, Yoshizaki K, Ishige M; Working Group for ‘Guidelines for the use of palivizumab in Japan for additional indications’. Mori M, et al. Among authors: hasegawa h. J Infect Chemother. 2024 Dec 12:S1341-321X(24)00335-0. doi: 10.1016/j.jiac.2024.12.017. Online ahead of print. J Infect Chemother. 2024. PMID: 39674346 Review.
An outbreak of influenza A(H1N1)pdm09 antigenic variants exhibiting cross-resistance to oseltamivir and peramivir in an elementary school in Japan, September 2024.
Takashita E, Shimizu K, Usuku S, Senda R, Okubo I, Morita H, Nagata S, Fujisaki S, Miura H, Kishida N, Nakamura K, Shirakura M, Ichikawa M, Matsuzaki Y, Watanabe S, Takahashi Y, Hasegawa H. Takashita E, et al. Among authors: hasegawa h. Euro Surveill. 2024 Dec;29(50):2400786. doi: 10.2807/1560-7917.ES.2024.29.50.2400786. Euro Surveill. 2024. PMID: 39668762 Free PMC article.
Ceftriaxone encephalopathy in a very elderly dialysis patient.
Nakamura Y, Yamamoto R, Shioda Y, Iwashita T, Shimizu T, Maeshima A, Hasegawa H, Ogawa T. Nakamura Y, et al. Among authors: hasegawa h. CEN Case Rep. 2024 Dec 9. doi: 10.1007/s13730-024-00953-4. Online ahead of print. CEN Case Rep. 2024. PMID: 39653878 Free article.
3,896 results